MedTrace Logo

Epigenetic Biomarkers for Alzheimer's Disease

NCT04081285 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-04-29

No results posted yet for this study

Summary

Alzheimer's disease (AD) is a neurodegenerative disorder with no know cure. The pathogenesis of late onset AD (LOAD) is complex and multifactorial in nature, with multiple susceptibility genes and environmental factors at interplay.

The objective of this study is to improve our understanding of the risk factors of LOAD by conducting an epigenome wide study within patients of LOAD contrasted against their cognitively normal siblings.

Conditions

  • Alzheimer Disease

Sponsors & Collaborators

  • Hong Kong University of Science and Technology

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Timothy Kwok · Chinese University of Hong Kong

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04081285 on ClinicalTrials.gov